Group One Trading, L.P. Adaptimmune Therapeutics PLC Transaction History

Group One Trading, L.P.

  • $3.01 Billion
  • Q2 2024

A detailed history of Group One Trading, L.P. transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Group One Trading, L.P. holds 34,037 shares of ADAP stock, worth $35,398. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,037
Previous 22,367 52.18%
Holding current value
$35,398
Previous $35,000 5.71%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.83 - $1.47 $9,686 - $17,154
11,670 Added 52.18%
34,037 $33,000
Q1 2024

May 10, 2024
BUY
$0.7 - $1.75 $15,621 - $39,053
22,316 Added 43756.86%
22,367 $35,000
Q4 2023

Feb 14, 2024
BUY
$0.43 - $0.79 $21 - $40
51 New
51 $0
Q1 2023

May 12, 2023
SELL
$1.06 - $2.16 $2,640 - $5,380
-2,491 Reduced 13.09%
16,541 $18,000
Q4 2022

Feb 09, 2023
SELL
$1.05 - $2.53 $2,100 - $5,060
-2,000 Reduced 9.51%
19,032 $27,000
Q3 2022

Nov 09, 2022
BUY
$1.06 - $2.41 $2,120 - $4,820
2,000 Added 10.51%
21,032 $23,000
Q2 2022

Aug 11, 2022
SELL
$1.33 - $2.28 $4,256 - $7,295
-3,200 Reduced 14.39%
19,032 $32,000
Q1 2022

May 12, 2022
BUY
$1.73 - $4.06 $563 - $1,323
326 Added 1.49%
22,232 $46,000
Q4 2021

Feb 11, 2022
BUY
$3.5 - $5.68 $52,962 - $85,949
15,132 Added 223.38%
21,906 $82,000
Q3 2021

Nov 12, 2021
SELL
$3.44 - $6.37 $154,645 - $286,363
-44,955 Reduced 86.9%
6,774 $35,000
Q2 2021

Aug 10, 2021
BUY
$3.86 - $5.78 $137,693 - $206,184
35,672 Added 222.16%
51,729 $220,000
Q1 2021

May 12, 2021
BUY
$4.9 - $6.83 $76,258 - $106,295
15,563 Added 3150.4%
16,057 $85,000
Q4 2020

Feb 10, 2021
SELL
$4.0 - $9.2 $484 - $1,113
-121 Reduced 19.67%
494 $3,000
Q3 2020

Nov 12, 2020
SELL
$7.66 - $10.78 $214,525 - $301,904
-28,006 Reduced 97.85%
615 $5,000
Q2 2020

Aug 13, 2020
BUY
$2.58 - $12.1 $73,842 - $346,314
28,621 New
28,621 $287,000
Q2 2019

Aug 09, 2019
SELL
$3.23 - $5.41 $21,456 - $35,938
-6,643 Closed
0 $0
Q1 2019

May 13, 2019
SELL
$3.63 - $6.06 $46,761 - $78,064
-12,882 Reduced 65.98%
6,643 $29,000
Q4 2018

Feb 06, 2019
BUY
$3.76 - $14.16 $35,896 - $135,185
9,547 Added 95.68%
19,525 $112,000
Q3 2018

Nov 08, 2018
BUY
$8.27 - $13.56 $59,701 - $97,889
7,219 Added 261.65%
9,978 $135,000
Q2 2018

Aug 14, 2018
BUY
$10.42 - $13.74 $28,748 - $37,908
2,759 New
2,759 $33,000
Q1 2018

May 11, 2018
SELL
$7.1 - $11.56 $1,420 - $2,312
-200 Closed
0 $0
Q3 2017

Nov 15, 2017
BUY
$4.93 - $8.93 $986 - $1,786
200
200 $2,000

Others Institutions Holding ADAP

# of Institutions
81
Shares Held
152M
Call Options Held
78.5K
Put Options Held
36.5K
View Full List

About Adaptimmune Therapeutics PLC

ADAP Quotes by TradingView
  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $170M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email